Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | VHL |
| Variant | V166F |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | VHL V166F lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). V166F results in reduced binding to elongin B and Cul2 in cell culture (PMID: 10587522), and therefore, is predicted to lead to a loss of Vhl protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
VHL mutant VHL inact mut VHL V166F |
| Transcript | NM_000551.4 |
| gDNA | chr3:g.10149819G>T |
| cDNA | c.496G>T |
| Protein | p.V166F |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000551.3 | chr3:g.10149819G>T | c.496G>T | p.V166F | RefSeq | GRCh38/hg38 |
| NM_000551.4 | chr3:g.10149819G>T | c.496G>T | p.V166F | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| VHL V166F | loss of function - predicted | mTORC1 Inhibitor VEGFR Inhibitor (Pan) VEGFR2 Inhibitor |